| 000 | 01681 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517214820.0 | ||
| 264 | 0 | _c20190923 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1600-0641 | ||
| 024 | 7 |
_a10.1016/j.jhep.2018.05.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRinker, Franziska | |
| 245 | 0 | 0 |
_aHepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B. _h[electronic resource] |
| 260 |
_bJournal of hepatology _c09 2018 |
||
| 300 |
_a584-593 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNucleosides _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aWithholding Treatment |
| 700 | 1 | _aZimmer, Christine L | |
| 700 | 1 | _aHöner Zu Siederdissen, Christoph | |
| 700 | 1 | _aManns, Michael P | |
| 700 | 1 | _aKraft, Anke R M | |
| 700 | 1 | _aWedemeyer, Heiner | |
| 700 | 1 | _aBjörkström, Niklas K | |
| 700 | 1 | _aCornberg, Markus | |
| 773 | 0 |
_tJournal of hepatology _gvol. 69 _gno. 3 _gp. 584-593 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhep.2018.05.004 _zAvailable from publisher's website |
| 999 |
_c28388492 _d28388492 |
||